Stoneridge (SRI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 sales were $213.8 million, down 9.8% sequentially and 10.2% year-over-year, impacted by seasonality, macroeconomic pressures, and reduced production volumes across all major end markets and geographies.
Operational efficiency improvements and cost controls reduced quality-related and operating expenses, partially offsetting market headwinds.
Year-to-date cash performance improved by $31.3 million versus the prior year, driven by working capital improvements and an $11.3 million inventory reduction.
Key growth initiatives include new business awards and program launches, notably MirrorEye becoming standard on several OEM platforms and the first Leak Detection Module program for a hybrid vehicle in China.
Reported a Q3 2024 net loss of $7.1 million ($(0.26) per share), compared to net income of $2.2 million in Q3 2023.
Financial highlights
Q3 2024 net sales: $213.8 million, down from $237.1 million in Q2 2024 and $238.2 million in Q3 2023.
Adjusted gross profit was $44.6 million (20.9% margin), down from $53.7 million (22.7%) in Q2 2024.
Adjusted operating income was $0.7 million (0.3% margin), compared to $5.4 million (2.3%) in Q2 2024.
Adjusted EBITDA was $9.2 million (4.3% margin), down from $16.1 million (6.8%) in Q2 2024, impacted by lower sales and $2.6 million in net non-operating expenses.
Cash and cash equivalents at quarter-end were $54.1 million.
Outlook and guidance
2024 revenue guidance updated to $895–$905 million (midpoint $900 million), reflecting a 3.6% decline in weighted average end markets and continued production headwinds.
Adjusted gross margin expected at ~21.5%; adjusted operating margin at ~1.0%; adjusted EBITDA $42–$44 million (~4.7% of sales); adjusted EPS $(0.35)–$(0.40).
MirrorEye revenue for 2024 expected at $65–$70 million, a 25% increase year-over-year but below initial expectations.
Focus remains on operational improvements, cost reduction, and cash performance to offset revenue declines and provide a strong foundation for 2025.
Latest events from Stoneridge
- 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025 - Margin gains and record product sales drive Q1, with guidance reaffirmed despite net loss.SRI
Q1 202524 Dec 2025 - 2025 proxy covers director elections, auditor ratification, compensation, and new LTIP.SRI
Proxy Filing2 Dec 2025 - Shareholders to vote on a new incentive plan consolidating all future equity awards.SRI
Proxy Filing2 Dec 2025